THE CHEMICAL STATE OF THE CALCIUM REACTING IN THE COAGULATION OF BLOOD by Quick, Armand J. & Stefanini, Mario
THE  CHEMICAL  STATE  OF  THE  CALCIUM  REACTING  IN  THE 
COAGULATION OF  BLOOD* 
Bx ARMAND J. QUICK AND MARIO STEFANINI~ 
(From the Department of Biockemistry, Marquette University Sckool of Medicine, 
Milwaukee) 
(Received for publication,  May 26, 1948) 
For nearly a half century almost every student of coagulation has accepted 
the  hypothesis that ionized calcium is  essential for coagulation.  Many in- 
vestigators, moreover, hold that ionized calcium acts as a catalyst.  The origin 
of these concepts can be traced first to Arthus and Pages (1) who in 1890 showed 
that blood was made incoagulable by sodium oxalate and that readdition of 
calcium  restored  normal  coagulation.  They justifiably concluded  that  cal- 
cium was necessary for the coagulation reaction.  Two years later Pekelharing 
(11) found that sodium citrate was equally effective as an anticoagulant, and, 
being no doubt influenced by the work of Arthus and Pages, he concluded that 
the  action  of sodium citrate  was  on  the  calcium.  Interestingly, Alexander 
Schmidt  (18)  refused to accept the idea  that calcium had a  specific  r61e in 
coagulationi  He  attributed  the  action  of both  sodium oxalate and sodium 
citrate to a non-specific salt effect. 
Considerable uncertainty remained until Sabbatani  (17)  explained the pe- 
culiar behavior of sodium citrate by stating that calcium forms a complex with 
this  compound whereby its ionization is  depressed,  and he postulated  that 
ionized calcium is essential for coagulation. 
Since Hammarsten  (4)  had previously found that  calcium was  necessary 
for the conversion of prothrombin to thrombin, it became generally accepted 
that ionized calcium was required for the activation of prothrombin.  Mora- 
witz (8) and Fuld and Spiro (3) incorporated the concept that ionized calcium 
acted catalytically in their "classical theory" of coagulation.  Thereafter few 
investigators had the temerity or sufficiently unconventional minds to ques- 
tion the indispensability of ionized calcium. 
It is well established that part of the plasma calcium is free or ionized and 
part is bound and non-diffusible.  It has been estimated by various methods 
that normally about one-half of the total calcium is bound or unionized.  When 
Vines  (24)  found that only one-seventeenth of the  total calcium present in 
serum was required to bring about a  normal coagulation time of decalcified 
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blood, he concluded that only bound calcium participated in coagulation.  Scott 
and Chamberlain  (19)  reported similar findings.  More recently Nordb5  (9) 
found that 0.15 to 0.18 m~ of calcium per liter of plasma was necessary to cause 
coagulation.  This amount of calcium is only one-fifteenth of the total found 
in plasma; nevertheless, he assumes that this fraction is ionized, because it was 
ionized calcium which he  added to decalcified plasma.  Ransmeier and Mc- 
Lean  (16)  determined that  the minimal  Ca  ++  concentration required for the 
coagulation of citrated plasma  was  0.28 m~ per liter of human plasma  and 
0.18 mM per liter of dog plasma.  These values are similar to those of Nordb5 
who worked with beef and horse plasma.  In both studies it was assumed that 
it was the minimum amount of calcium required to initiate coagulation that 
was significant. 
The introduction by Steinberg (22)  of a  resin, amberlite, which quantita- 
tively removes calcium from the  blood, has  made  possible a  new approach 
to  the problem of calcium in  coagulation.  By employing this new reagent, 
Quick (14) found that the minimum amount of calcium required to produce a 
normal prothrombin time, which is the real criterion of maximum and optimal 
coagulation, is 0.0012 M for human and 0.0004 M for dog plasma.  It was found 
(15)  further that  if the amount of calcium added is below these levels, the 
amount of prothrombin consumed or converted is quantitatively reduced even 
though thromboplastin is in excess.  Neither of these findings are in accord 
with the theory that calcium acts ionically and plays the r61e of a catalyst. 
From this short historical review it should be obvious that the concept that 
it is ionized calcium in the r61e of a catalyst which is responsible for the activa- 
tion of prothrombin, is still a  theory and not an established fact.  Its main 
support is the assumption that sodium citrate acts as an anticoagulant by de- 
pressing the ionization of calcium.  It is the purpose of this paper to reexamine 
critically the r61e of calcium in the coagulation mechanism by three different 
approaches:  (1) the decalcifying action of sodium oxalate; (2) the anticoagulant 
action of sodium citrate; and (3) the influence of calcium on the stability of the 
labile factor of prothrombin. 
EXPERIMENTAL 
Determination  of Prothrombin  Time 
The method of Quick was used.  The thromboplastin prepared by dehydration of 
rabbit brain with acetone consistently yielded a prothrombin time of 11½ to 12 seconds 
for human blood. 
Preparation  of Stable Native Plasma 
Blood was collected by venipuncture using a needle and syringe coated with silicone 
(General Electric dri film 9987).  The syringe was kept in ice prior to use, and the 
blood was immediately transferred to silicone-coated tubes immersed in an ice bath, ARMAND  J.  QUICK  AND  MARIO  STE]~ANINI  193 
and covered with  mineral  oil.  The chilled blood was centrifuged  for 15 minutes  at 
4,000 R.P.M. in an angle  centrifuge  at  refrigerator  temperature.  The plasma was 
removed with a silicone-coated pipette and transferred  to a silicone-coated test tube. 
Preparation of Tricalcium Phosphate 
To a solution containing  158 gm. of trisodium phosphate in 1 liter of distilled water, 
an equal volume of calcium chloride solution containing 66.6 gin. of the anhydrous salt 
was added slowly with vigorous stirring.  The pH was adjusted to 7.  The precipitate, 
Ca3(PO4)2, was washed by decantation until the sodium chloride was removed.  The 
suspension was made up to 1 liter and it therefore had a concentration of 0.2 •.  From 
this stock suspension, a 0.008 ~ preparation was made by diluting  4 cc. with 96 cc. 
of distilled water.  One cc. of the dilute  suspension was transferred  to a small test 
•  tube which was centrifuged  to pack the tricalcium  phosphate.  The water was poured 
off, the tube drained,  and  1 co. of plasma  added.  The tricalcium  phosphate and 
plasma were mixed and allowed to stand at room temperature for 10 minutes.  The 
adsorbent was removed by centrifugation. 
The Removal of Calcium with Amberlite 
The method as outlined by Quick (14) and Stefanini (21) was used. 
Quantitative  Measurement  of  the  Action  of  Sodium  Oxalate on  Prothrombin 
Activity 
Stewart  and  Percival  (23)  and  later  Nordb6  obtained  evidence  that  the 
sodium oxalate did not inhibit coagulation instantaneously, but required con- 
siderable  time.  In  1940  Quick  (12)  studied  this  action  quantitatively  by 
measuring the increase of the prothrombin time of plasma after the addition 
of an  accurately measured  amount of  sodium oxalate.  He found that  the 
speed  of inhibition increased  in  proportion to  the amount of oxalate added. 
Because of the importance of these results, the experiment was repeated with 
greater precision and on a larger number of plasmas.  The data are presented 
in Table I. 
It will be observed that the addition of 0.02 cc. of 0.1 M sodium oxalate to 
1 cc. of human plasma caused only a  slow increase in the prothrombin time. 
Yet, this amount of sodium oxalate brings the concentration to 0.002 ~  in the 
plasma.  Since the calcium level averages 10 mg. per 100 cc. which is 0.0025 
M, the amount of sodium oxalate added is sufficient to precipitate approximately 
80 per cent of the total calcium.  Since only half of the calcium is ionized and 
since this fraction is rapidly removed as insoluble calcium oxalate, it appears 
unlikely that the slow increase in prothrombin time is due to the removal of 
ionized calcium.  Even when the sodium oxalate is increased to 0.004 ~  (by 
adding 0.04 cc. to 1 cc. of plasma) which is 60 per cent more than is required 
to  precipitate  the  total  calcium,  the  diminution  of prothrombin  activity is 
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seconds.  Under these conditions, the ionized calcium can come only from dis- 
solved calcium oxalate.  Since the  solubility is less  than  0.0006 gm. per  100 
cc., the concentration of ionized calcium is below 0.000004 M, which is far less 
than the values calculated as minimal by Nordbti and by Ransmeier and Mc- 
Lean. 
The most logical explanation for the action of sodium oxalate is that instead 
of only precipitating ionized calcium, it also removes calcium from a compound 
which  is  essential  for  coagulation.  Apparently  this  compound  has  a  great 
avidity for calcium and therefore a  relatively large excess of sodium oxalate is 
required  to decalcify it  completely.  An examination  of the  data  of Table  I 
TABLE I 
The Speed of Inhibition of the Prothrombin Activity by Sodium Oxalate and Sodium Citrate 
Prothrombin time 
Time after mixing  ......................  30 rain. 
Am ount of reagent added to 1 cc. 
of plasma 
Sodium oxalate 0.1 
0.02 cc. 
0.04 cc. 
0.06cc. 
Sodium citrate 0.1 
0.02 cc. 
0.04 cc. 
0.06 cc. 
0.08 cc. 
0  I  10 sec.  1 min.  5 mln. 
$e¢.  se¢.  r  $e¢. 
12 
12 
12 
12 
12 
12 
12 
12 
12 
17 
12½ 
15 
28 
135 
12{  14 
18  52 
75 
12½  * 
15  14 
28  27½ 
150  135 
lOmin. 
$¢.C. 
18 
165 
13 
25 
135 
S~C. 
330 
125 
* Spontaneous coagulation. 
clearly indicates  that the reaction follows the law of mass action.  Since this 
compound has a  great affinity for calcium,  it is logical to assume that when 
ionized calcium is added to oxalated or otherwise decalcified plasma, a prompt 
resynthesis  of this  calcium  compound  occurs with  an  immediate  restoration 
of the coagulability of the plasma  especially if an excess of thromboplastin is 
present.  This temporary coagulability in the presence of sodium oxalate has 
been  interpreted  by both  Nordb6  (9)  and  Owren  (10)  as  due  to  the  added 
ionized  calcium remaining  as  such for a  short period.  Quick  (14),  however, 
showed that this activity remains considerably longer than the time required 
for the complete precipitation  of ionized calcium as the oxalate salt. 
It is  difficult  to find a  simpler and more obvious explanation  for the  slow 
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moves calcium from a  compound which is essential in the conversion of pro- 
thrombin to thrombin, but which is inactive in its decalcified state.  Sodium 
citrate appears to act in an entirely different manner.  It exerts its maximum 
depressing action quickly and it only gradually becomes more inhibitory as 
its concentration is increased.  The nature of the action of sodium citrate is 
shown in the following experiments. 
The Action of Sodium Citrate on Prothrombin 
Bordet and  Delange  (2)  discovered that  tricalcium phosphate removes by 
adsorption a  plasma  constituent essential for coagulation.  They concluded 
that  it  was  serozyme  (prothrombin).  Subsequently  other  agents  such  as 
barium  sulfate,  magnesium hydroxide, and aluminum hydroxide were found 
which likewise remove prothrombin by adsorption.  It was generally accepted 
TABLE II 
The Blocking A orion of  Sodium Citrate on the Absorption of Prothrombin  by Tricalciura Phosphat • 
Molarity of sodium citrate 
of which I volume was added 
to 9 volumes  of plasma .... 
Rabbit .............. 
Dog  ................. 
Man ................ 
Prothrombln time after absoz ,tion  with Cas(PO6)z 
;rol*2°n" .....  0.25  0.20  0.15  0.12  0.I0  0.085  0.065  0.045  0.025  0 
$ec.7  55c.7  $P-~'7,  105~"  11,$$0"  '$ec"  sec. tM'-,¢..l$,c.18 $$c.  se~. 
s½  s½  s½  5½  s½  3½  17  21  25  .  8  /10  /18  [481. 
12  1,2  112  [12  1,5  [ls½  ls½t19  [ss  I lSSt. 
* Control.  Prothrombin time of oxalated plasma not treated with Cas(PO4)2. 
:~ For low coricentrations  of sodium citrate, oxalated plasma in place of native plasma was 
used to prevent spontaneous coagulation. 
that the prothrombin thus removed was a  unitary substance which required 
only  thromboplasin  and  calcium  for  its  activation.  This  concept  lost  its 
validity when in  1943  Quick  (13) found that prothrombin, or perhaps more 
accurately, the  chemical aggregate on which prothrombin activity depends, 
consists of a complex, only part of which is adsorbable by aluminum hydroxide. 
To avoid confusion, however, the term prothrombin, will be reserved in this 
paper for the adsorbable fraction while the designation of the labile factor will 
be applied to the non-adsorbable part of the complex which diminishes when 
plasma is stored. 
The adsorption of prothrombin by tricalcium phosphate which occurs readily 
from oxalated plasma fails to take place when sodium citrate is used.  There 
is moreover a  definite quantitative relationship between the concentration of 
sodium citrate and the non-adsorbability of prothrombin.  This relationship 
was studied and the results obtained are recorded in Table II.  It can be seen 
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concentration of a little more than 0.01 ~  before all the prothrombin remains 
non-adsorbable.  Below  that  concentration  some  of  the  prothrombin  is  re- 
moved by tricalcium phosphate and therefore the pro  thrombin time becomes 
prolonged.  Rabbit blood requires a somewhat higher concentration of sodium 
citrate, approximately 0.02 ~ to prevent completely adsorption of prothrombin, 
whereas dog blood is similar to human blood in its response to sodium citrate. 
This finding clearly suggests that sodium citrate combines with prothrombin 
and thereby blocks its adsorption with agents such as tricalcium phosphate. 
Such a union obviously does not occur between prothrombin and the oxalate 
radical.  To rule out the possibility that prothrombin itself is not adsorbable 
but  may become so after decalcification by sodium  oxalate,  several  studies 
(recorded in Table III)  were made.  Thus,  native hemophilic plasma  when 
treated with tricalcium phosphate loses all prothrombin activity, but if mixed 
TABLE III 
Prothrombin Time of Plasma (in Seconds) 
•  Amberlite-  Oxalated  Nattve  treated 
Control* ................................................  [  12  ]12  /  12 
After treatment with Ca3(PO4)2 ............................  [  oo  ]  oo  [  ¢~ 
After  addition  of  sodium  citrate  and  treatment  with  Ca3-[  [  ] 
(PO4)~$ ...............................................  [  12  [  12  ]  12 
* Control.  0.1 cc. of plasma, 0.1 cc. of thromboplastin, and 0.1 cc. of 0.02 ~t CaCh. 
To 0.9 cc. of plasma, 0.1 cc. of 0.2 ~ sodium citrate was added. 
with sodium citrate before the addition of the adsorbing agent, it retains its 
prothrombin  completely.  Blood treated  with  amberlite,  the  agent  that  re- 
moves calcium and so renders it incoagulable, will when treated with tricalcium 
phosphate lose its prothrombin activity.  If however, sodium citrate is added, 
the adsorbent no longer is able to take out the prothrombin.  In fact the ad- 
sorption  is  blocked  even in  oxalated  plasma  if sodium  citrate  in  sufficient 
amounts is added (Tables II and III).  The removal of prothrombin by tri- 
calcium phosphate is therefore independent of calcium. 
The conclusion that prothrombin forms a  union  with  sodium citrate and 
thereby loses its adsorbability can be accepted without hesitation, but the moot 
question remaining is: does this combination with citrate cause the prothrombin 
to become inactive?  In other words, is sodium citrate an antiprothrombin? 
The difficulty in arriving at a solution of this problem is that calcium also forms 
a  complex with the citrate radical, ~/s a  result of which calcium ionization is 
depressed.  If one considers the low Ca  ++ in  the oxalated plasma  of Table I 
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citrate required to inhibit coagulation is sufficient to depress Ca  ++ below this 
effective level  since  the  primary dissociation  constant  of  calcium  citrate  is 
fairly  high.  According  to  Hastings,  McLean,  and  their  associates  (5)  the 
pKca elUat~ is  3.22.  Further  work will,  however, be required  before  a  final 
answer can be given. 
It follows that one must consider how the addition  of calcium chloride  to 
citrated plasma restores coagulation,  According to the old and generally ac- 
cepted concept, it merely furnished calcium ions in excess to the ones depressed 
by the citrate.  On the basis of evidence that prothrombin combines with the 
TABLE IV 
The Prothrombin Time Obtained on Citrated Plasma* by Substituting Magnesium and Strontium 
Chloride for Calcium Chloride 
Molarity of sodium citrate  (1  volume 
added to 9 volumes of blood) .......... 
CaCI~  0.01 xt 
0.02 
MgCI2  0.01 
0.02 
0.03 
SrCI~  0.01 
0.02 
0.03 
0.2 
45 
11 
120 
36 
58 
26 
Prothrombin time 
0.15  0.1 
15  11 
11  12 
180  30 
32  15 
22  16 
60  25 
25  16 
22  17 
0.075 
se~:. 
11 
12 
14 
14 
16 
16 
16 
18 
0.05 
,-¢8C. 
11 
12 
14 
13½ 
17 
14 
14½ 
16 
* The citrated blood was kept in ice bath until tested. 
citrate  radical,  a  new  explanation  can  be  offered; namely,  calcium chloride 
removes the citrate from prothrombin thereby restoring it to its original state, 
This can be expressed as follows: 
Prothrombin-citrate  +  CaCh ~  prothrombin  +  Ca citrate complex. 
To be sure, the Ca  ++ also are increased. 
If  this  concept  is  correct,  magnesium  and  strontium  should  also  restore 
coagulation when added  to citrated plasma.  The results given in Table IV 
show  that both possess the power to do  this.  Strontium itself has a  much 
weaker coagulation  action  than  calcium while magnesium has only a  feeble 
activity as Stefanini and Quick  (20)  have recently shown.  Their action can 
therefore be explained either as liberating prothrombin from the citrate radical 
or increasing the  Ca  ++ by coming in equilibrium with  calcium citrate.  The 
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(1) Prothrombin-citrate +  MgCI2 ~  prothrombin +  Mgcitrate complex. 
(2) Ca citrate  +  MgCI2 ~  3¢g citrate  +  CaCh 
Ca  ++ . 
The fact that strontium and magnesium become less effective as the citrate 
concentration is increased is in the favor of the first explanation.  The greater 
the concentration of citrate the firmer its union with prothrombin and the less 
complete the liberation of prothrombin.  Were the action of magnesium chlo- 
ride merely one of increasing Ca  -~+, slight changes in the citrate concentration 
should be without any appreciable effect on the coagulation time. 
Thus the restoration of coagulation in citrated plasma  by the addition of 
calcium chloride can be explained as satisfactorily by the removal of citrate 
from prothrombin as by increasing the Ca  ++.  Nevertheless, a definitive solu- 
tion  will  require  additional  data  obtained by more direct  experimental ap- 
proaches. 
The Relation of the Stability of the Labile Factor to the Calcium Concentration of 
the Plasma 
When oxalated human  plasma  is stored in  an open container at ordinary 
refrigerator temperature, prothrombin activity diminishes  relatively rapidly 
whereas  undecalcified or native plasma  (such  as  hemophilic  which  remains 
fluid) fails to show this loss (i3, 20).  Likewise, plasma from blood mixed with 
0.1 ~  sodium citrate (1 volume to 9 volumes of blood) does not show this rapid 
and marked increase in prothrombin time when stored, but if the concentration 
of sodium citrate is increased to 0.2 ~  the disappearance of prothrombin ac- 
tivity is similar to that occurring in oxalated plasma. 
In Table V  the disappearance of prothrombin activity from plasma  under 
various types of conditions is studied.  It will be observed that theprothrombin 
time increases in 24 hours from a  normal of 11½ to 12 to 14 to 15  seconds in 
oxalated, 0.2 ~ citrated and amberlite-treated plasma, whereas a decrease or an 
insignificant increase occurs in the 0.1 M citrated and native plasma.  In two 
plasmas (oxalated and amberlite-treated) in which diminution of prothrombin 
activity occurs,  one is  certain  that  decalcification has  taken place.  In  the 
native plasma  in which  the calcium is unchanged,  the prothrombin remains 
essentially unaltered.  This clearly suggests  that  the  labile factor, which  is 
responsible for the decrease of prothrombin activity, is stable in the presence 
of calcium, and is inactivated or destroyed in decalcified plasma.  Whether 
the labile factor itself is a calcium compound cannot be decided until more ex- 
perimental information is available. 
The important suggestion accruing from the observation of the difference in 
effect of 0.1 x~ and 0.2 M sodium citrate is that the latter depresses the calcium ARMAND J.  QUICK AND MARIO STEFANINI  199 
ion concentration  sufficiently so  that  the labile factor  diminishes, while  the 
weaker concentration of sodium citrate does not.  When 0.1 sodium citrate is 
added to amberlite-treated plasma which is already deprived of calcium, the 
rate of prothrombin diminution is little affected.  This clearly indicates that 
the stability of the labile factor in 0.1 ~  sodium citrate plasma is due to insuf- 
ficient decalcification.  In other words, sufficient calcium  remains  to  protect 
the labile factor.  Since even a  lower concentration  than 0.1  M is enough  to 
inhibit the coagulation of human  plasma, an appreciable Ca  ++ concentration 
must still be present at the citrate level at which incoagulability occurs. 
TABLE V 
The Influence of the Anticoagulant on the Loss of Prothrombin Actidty during Storage 
Antlcosgulsnt 
Sodium oxalate 0.1 M  .............................. 
Sodium citrate 0.1 ~ ............................... 
Sodium citrate 0.2 M  .............................. 
Amberlite IR-100 ................................. 
Amberlite IR-100 -b sodium oxalate 0.1 ~* .......... 
Amberlite IR-100 +  sodium citrate 0.1 M* .......... 
Nones .......................................... 
Volume 
used 
CC. 
0.3 
0.3 
0.3 
0.3 
0.3 
Volum, 
of bloo 
¢¢. 
2.7 
2.7 
2.7 
3.0 
2.7 
2.7 
3.0 
Prothrombin time 
Imme. I  Af~r ~ *Afar  48 
diate  hrs.  hrs. 
$¢6.  $~¢.  $$C. 
12  15  t  17½ 
11½  10  11 
12  14  15 
11½  14  15 
11½  14  18 
11½  14½  18 
12  12½  13 
* The sodium oxalate or citrate was added to blood which was previously treated with 
smberlite IR-100. 
S By collecting blood in silicone-coated glassware and centrifuging it at high speed, plasma 
was obtained which remained fluid in silicone-coated  test tubes. 
Two important facts:  (1) the indispensability of the labile factor in coagula- 
tion  and  (2)  its instability in  decalcified plasma  should  ultimately serve as 
important keys to the r61e of calcium in the formation of thrombin. 
DISCUSSION 
The almost universally accepted idea that it is the ionized calcium of the 
blood that participates in the coagulation reaction and that it functions as a 
catalyst is a  theory and  by no  means  an  established fact.  In  this  study  a 
series of experiments were  carried out which yielded results  that  are not  in 
accordance with this theory.  The action of sodium oxalate in inhibiting coagu- 
lation is relatively slow.  Since the precipitation of Ca  ++ by soluble oxalates 
is a  rapid reaction, the behavior of sodium oxalate cannot be adequately ex- 
plained by its action of merely removing free calcium.  It is more likely that 
it decalcifies a  compound which is essential for the formation of thrombin. 
Of  particular  importance  is  the  discovery  that  the  prothrombin  fraction 200  CALCILr~  REACTING  IN  BLOOD  COAGULATION 
which is adsorbed by tricalcium phosphate from oxalated plasma is not re- 
moved by this agent from citrated plasma.  It appears fairly certain thatthe 
citrate radical combines with prothrombin and it is suggested  that the pro- 
thrombin is thereby inactivated.  While this is admittedly not unequivocally 
proved, it does challenge the explanation that sodium citrate exerts its anti- 
coagulant action by depressing  the ionization of calcium.  A  study of the 
stability of the labile  factor of the prothrombin complex indicates that de- 
calcification is not complete  at the citrate level required  to stop coagulation 
completely. 
The theory that ionized calcium is required for the activation of prothrombin 
has been  sterile  as an aid to unravel the riddle of coagulation and probably 
has actually led many investigators to treat calcium indifferently.  With the 
evidence marshalled against the theory of the indispensability of ionized cal- 
cium,  the burden of proof now rests on those who maintain the validity of 
the theory and it is for them to provide data to support it.  This statement has 
no polemic intent.  It is merely to stress the urgency of further study. 
The finding that adsorbents such  as  tricalcium phosphate do not adsorb 
the prothrombin fraction (which has generally been regarded as the classical 
unitary prothrombin) from citrated plasma makes the interpretation of several 
recent  studies  exceedingly  difficult.  Lenggenhager's hypothesis  (6)  of  the 
existence of a prothrombokinin, which is presumably similar to a prothrombo- 
plastin, is based  on work done on citrated plasma and adsorption with tri- 
calcium  phosphate.  Recently Milstone (7)  in an extended study similar  to 
Lenggenhager's,  prepared  a  fraction which  he designates  prothrombokinase 
from euglobulin obtained from citrated plasma.  He treated a solution of the 
euglobulin with BaSO4, apparently to free it from prothrombin.  In the light 
of the present findings, it seems highly probable  that his preparation contained 
some of the prothrombin citrate which is non-adsorbable.  To be certain the 
experiment should be repeated using euglobulin isolated from oxalated plasma. 
These statements should not be construed as critical evaluations of Lenggen- 
hager's and Milstone's work.  They are cited merely to point out the possible 
pitfalls in applying methods such as adsorption which yield successful results 
with oxalated plasma, but not with citrated plasma. 
The influence of storage on prothrombin activity  is another point in question. 
In oxalated blood a decrease of 50 per cent may occur in 24 hours.  Yet War- 
ner, DeGowin, and Seegers (25) found that the prothrombin during storage in 
citrated plasma decreased only gradually, and required 3 weeks to reach the 
50 per cent level.  The results recorded  in Table V hold the answer to this 
discrepancy of  results.  In  plasma  containing 0.2  to  0.3  per  cent  sodium 
citrate, the amount used in blood  for transfusion, the labile  factor is stable 
and therefore no rapid decrease in prothrombin activity occurs, in contrast to 
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SUMMARY 
1. The widely accepted theory that calcium participates in the coagulation 
mechanism in the form of Ca  ++ and acts as a catalyst is not in accord with sev- 
eral important experimental findings: 
(a)  The anticoagulant action of sodium oxalate is much slower than the 
precipitation of ionized calcium as the oxalate salt. 
(b)  Sodium citrate begins to depress prothrombin activity at a concentra- 
tion at which ionized calcium is still present.  The inability of tricalcium 
phosphate to adsorb prothrombin from citrated plasma indicates that citrate 
forms a complex with prothrombin and it is postulated that prothrombin is 
thereby inactivated. 
(c)  In plasma which is decalcified, i.e.  in which the Ca  ++ is markedly re- 
duced, the labile factor of prothrombin rapidly decreases.  A concentration 
of 0.01  1~ sodium citrate sufficient to inhibit coagulation does not depress 
Ca  ++ enough to cause diminution of the labile factor, whereas when the con- 
centration is increased to 0.02 ~  the labile factor decreases as rapidly as in 
oxalated plasma. 
2.  It is postulated that calcium functions in coagulation not as Ca  ++ but 
as combined with a component which is part of the prothrombin complex that 
is not adsorbed by tricalcium phosphate.  A concentration of sodium citrate 
just sufficient to inhibit coagulation is not enough to remove calcium from the 
essential  prothrombin  component.  The  primary  anticoagulant  action  of 
sodium citrate is therefore not decalcification but antiprothrombic. 
3.  It has been shown that citrated plasma  is basically different from oxa- 
lated plasma in several important aspects.  Unless cognizance is taken of these 
differences, serious errors and misinterpretations of experimental findings may 
be made. 
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